InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,727.04
(
1.94%
)
US TECH 100
19,406.00
(
2.91%
)
Dow Jones
42,106.05
(
1.45%
)
Brent Oil
74.18
(
2.49%
)
Bitcoin
63,666.05
(
3.23%
)
Post# of 253158
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Gbathat

Send PM Follow Ignore
Followers 14
Posts 1306
Boards Moderated 0
Alias Born 06/05/2007

Gbathat

Re: None

Wednesday, 05/26/2021 2:01:50 PM

Wednesday, May 26, 2021 2:01:50 PM

Post# of 253158
COVID play- $ARFXF ProMIS Neurosciences just announced commercialization of its highly selective and specific serology test for COVID antibodies.

It can measure your response to infection or vaccination and the level of immunity you have to the different variants.

The company market cap is $50M. The annual COVID serology test market is in the $1-2B range. There are some competitors out there, but a lot of the products on the market are crap. So their market penetration could be high.

This company also has some awesome products in the pipe of Alzheimer's treatment, and that market is massive and largely unmet.

more info at:

https://promisneurosciences.com/news/promis-neurosciences-initiates-commercialization-of-covid-19-serology-assay/

and

covidimmunitypassport.com

God grant me the serenity to deal with the things I cannot change; courage to change the things I can and should; and wisdom to know the difference.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up